Newswise News from NIH, National Eye Institute (NEI) Latest news from NIH, National Eye Institute (NEI) on Newswise en-us Copyright 2024 Newswise Newswise News from NIH, National Eye Institute (NEI) 115 31 / /images/newswise-logo-rss.gif The latest mpox outbreak and its threat to vision /articles/the-latest-mpox-outbreak-and-its-threat-to-vision/?sc=rsin /articles/the-latest-mpox-outbreak-and-its-threat-to-vision/?sc=rsin Tue, 27 Aug 2024 15:30:53 EST Monkeypox virus (mpoxv) has re-emerged, designated on August 14 as a global emergency by the World Health Organization. Newly evolved strains of mpox viruses can efficiently spread among people. In addition to skin rashes, mpox infection can cause eye complications including inflammation of the clear tissue covering the iris and pupil called the cornea (keratitis), the tissue covering the white of the eye and the underside of the eyelid (conjunctivitis, or pink eye), and the eyelid (blepharitis). NIH, National Eye Institute (NEI) NIH researchers discover potential therapeutic target for degenerative eye disease /articles/nih-researchers-discover-potential-therapeutic-target-for-degenerative-eye-disease/?sc=rsin /articles/nih-researchers-discover-potential-therapeutic-target-for-degenerative-eye-disease/?sc=rsin Fri, 26 Jul 2024 17:05:48 EST NIH, National Eye Institute (NEI) Supplements slow disease progression during late stage of "dry" age-related macular degeneration /articles/supplements-slow-disease-progression-during-late-stage-of-dry-age-related-macular-degeneration/?sc=rsin /articles/supplements-slow-disease-progression-during-late-stage-of-dry-age-related-macular-degeneration/?sc=rsin Tue, 16 Jul 2024 12:05:24 EST In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision. NIH, National Eye Institute (NEI) NIH researchers discover a new face-detecting brain circuit /articles/nih-researchers-discover-a-new-face-detecting-brain-circuit/?sc=rsin /articles/nih-researchers-discover-a-new-face-detecting-brain-circuit/?sc=rsin Tue, 02 Jul 2024 11:00:00 EST Scientists at the National Institutes of Health (NIH) have uncovered a brain circuit in primates that rapidly detects faces. The findings help not only explain how primates sense and recognize faces, but could also have implications for understanding conditions such as autism, where face detection and recognition are often impaired from early childhood. NIH, National Eye Institute (NEI) Discovery in hibernating animals could extend the shelf life of cells and tissues for transplantation   /articles/discovery-in-hibernating-animals-could-extend-the-shelf-life-of-cells-and-tissues-for-transplantation/?sc=rsin /articles/discovery-in-hibernating-animals-could-extend-the-shelf-life-of-cells-and-tissues-for-transplantation/?sc=rsin Tue, 11 Jun 2024 12:05:40 EST Research led by scientists at the National Eye Institute and Sun Yat-sen University, Guangzhou, China points to a potential strategy for extending the cold storage shelf life of donor cells and tissues, such as those of the pancreas, an organ crucial for making insulin. NIH, National Eye Institute (NEI) Babies Attend to Clues of Meaning as They Take in Complex Visual World /articles/babies-attend-to-clues-of-meaning-as-they-take-in-complex-visual-world/?sc=rsin /articles/babies-attend-to-clues-of-meaning-as-they-take-in-complex-visual-world/?sc=rsin Wed, 27 Mar 2024 11:05:37 EST Findings from a National Eye Institute-supported study show for the first time that when babies look at photos of unfamiliar everyday scenes, such as an office or a lab, they tend to fixate on the same regions where adults find meaning. This inclination to home in on what's interesting or meaningful grows more pronounced as babies age. The findings, published in Infancy, provide a more nuanced understanding of visual development, which may lead to earlier detection of brain-based causes of vision problems, such as cerebral/cortical visual impairment. NIH, National Eye Institute (NEI) NEI Study Points to 'Ground Zero' for AMD Development /articles/nei-study-points-to-ground-zero-for-amd-development/?sc=rsin /articles/nei-study-points-to-ground-zero-for-amd-development/?sc=rsin Wed, 27 Mar 2024 10:05:18 EST National Eye Institute researchers studying human retinas discovered 87 target genes where a mix of environmental factors likely influence one's risk of developing age-related macular degeneration (AMD), a leading cause of vision loss in people ages 65 and older. NIH, National Eye Institute (NEI) Inflammation-Reducing Drug Shows No Benefit for Dry Age-Related Macular Degeneration in Nih Trial /articles/inflammation-reducing-drug-shows-no-benefit-for-dry-age-related-macular-degeneration-in-nih-trial/?sc=rsin /articles/inflammation-reducing-drug-shows-no-benefit-for-dry-age-related-macular-degeneration-in-nih-trial/?sc=rsin Thu, 21 Mar 2024 11:30:33 EST The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National Institutes of Health. NIH, National Eye Institute (NEI) Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial /articles/inflammation-reducing-drug-shows-no-benefit-for-dry-age-related-macular-degeneration-in-nih-trial2/?sc=rsin /articles/inflammation-reducing-drug-shows-no-benefit-for-dry-age-related-macular-degeneration-in-nih-trial2/?sc=rsin Thu, 21 Mar 2024 11:05:08 EST NIH, National Eye Institute (NEI) New technique enhances quality control of lab-grown cells for AMD treatment /articles/new-technique-enhances-quality-control-of-lab-grown-cells-for-amd-treatment/?sc=rsin /articles/new-technique-enhances-quality-control-of-lab-grown-cells-for-amd-treatment/?sc=rsin Thu, 18 Jan 2024 15:05:51 EST Researchers at the National Eye Institute (NEI) have improved a crucial step in the production of retinal pigment epithelium (RPE), a tissue they grow in the lab from patient blood cells and are testing in a clinical trial as treatment for age-related macular degeneration (AMD). NIH, National Eye Institute (NEI) Metabolomics: A New Approach to Understanding Glaucoma /articles/metabolomics-a-new-approach-to-understanding-glaucoma/?sc=rsin /articles/metabolomics-a-new-approach-to-understanding-glaucoma/?sc=rsin Tue, 14 Nov 2023 18:05:10 EST Glaucoma remains one of the most common causes of vision loss and blindness in the U.S. and much of the world, disproportionately affecting older people, African Americans, and Hispanics and Latinos. NIH, National Eye Institute (NEI) Scientists discover external protein network can help stabilize neural connections /articles/scientists-discover-external-protein-network-can-help-stabilize-neural-connections/?sc=rsin /articles/scientists-discover-external-protein-network-can-help-stabilize-neural-connections/?sc=rsin Wed, 16 Aug 2023 11:00:00 EST The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons, according to a study in mice from the National Eye Institute (NEI) and the University of Freiberg, Germany. NIH, National Eye Institute (NEI) Intraocular corticosteroids best for treating complications of chronic inflammatory eye condition /articles/intraocular-corticosteroids-best-for-treating-complications-of-chronic-inflammatory-eye-condition/?sc=rsin /articles/intraocular-corticosteroids-best-for-treating-complications-of-chronic-inflammatory-eye-condition/?sc=rsin Tue, 13 Jun 2023 09:00:00 EST Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI). NIH, National Eye Institute (NEI) NEI Scientists publish recipe for making blood vessel cells from patient stem cells /articles/nei-scientists-publish-recipe-for-making-blood-vessel-cells-from-patient-stem-cells/?sc=rsin /articles/nei-scientists-publish-recipe-for-making-blood-vessel-cells-from-patient-stem-cells/?sc=rsin Tue, 16 May 2023 09:30:59 EST Researchers at NIH's National Eye Institute have published a detailed protocol for making three cell types that are key components to form blood vessels and capillaries. NIH, National Eye Institute (NEI) Extremely rare gene variants point to a potential cause of age-related macular degeneration /articles/extremely-rare-gene-variants-point-to-a-potential-cause-of-age-related-macular-degeneration/?sc=rsin /articles/extremely-rare-gene-variants-point-to-a-potential-cause-of-age-related-macular-degeneration/?sc=rsin Sat, 01 Apr 2023 11:00:00 EST A study from the National Eye Institute (NEI) identified rare genetic variants that could point to one of the general mechanisms driving age-related macular degeneration (AMD), a common cause of vision loss in older adults. NIH, National Eye Institute (NEI) FDA-approved drug shows promise in lab models for blinding childhood disease  /articles/fda-approved-drug-shows-promise-in-lab-models-for-blinding-childhood-disease/?sc=rsin /articles/fda-approved-drug-shows-promise-in-lab-models-for-blinding-childhood-disease/?sc=rsin Wed, 29 Mar 2023 12:05:07 EST A National Eye Institute-led team has identified a compound already approved by the U.S. Food and Drug Administration that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10 (LCA 10), an inherited retinal ciliopathy disease that often results in severe visual impairment or blindness in early childhood. NIH, National Eye Institute (NEI) Visually navigating on foot uses unique brain region /articles/visually-navigating-on-foot-uses-unique-brain-region/?sc=rsin /articles/visually-navigating-on-foot-uses-unique-brain-region/?sc=rsin Wed, 15 Mar 2023 08:45:29 EST Using vision to efficiently move through an area by foot uses a unique region of the brain's cortex, according to a small study funded by the National Eye Institute (NEI). NIH, National Eye Institute (NEI) AI-based systems can help identify rapidly advancing age-related macular degeneration /articles/ai-based-systems-can-help-identify-rapidly-advancing-age-related-macular-degeneration/?sc=rsin /articles/ai-based-systems-can-help-identify-rapidly-advancing-age-related-macular-degeneration/?sc=rsin Tue, 14 Mar 2023 15:35:57 EST Researchers supported by the National Eye Institute are developing artificial intelligence/machine learning (AI/ML)-based systems that not only screen for AMD but also predict which patients will likely progress to late within two years. The systems also evaluate separately one's risk for developing late wet (neovascular) AMD from one's risk for late dry (geographic atrophy) AMD. NIH, National Eye Institute (NEI) Eye experts weigh in on artificial tears in midst of infectious outbreak /articles/eye-experts-weigh-in-on-artificial-tears-in-midst-of-infectious-outbreak/?sc=rsin /articles/eye-experts-weigh-in-on-artificial-tears-in-midst-of-infectious-outbreak/?sc=rsin Thu, 02 Mar 2023 13:15:23 EST Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 64 people in 13 states, including 8 cases of vision loss, as well as lung and urinary tract infections, and one death. Federal agencies warned people to stop using EzriCare and Delsam Pharma artificial tears after tests of opened bottles used by those affected found a rare, extensively drug-resistant strain of P. aeruginosa. The strain had never been reported in the United States.What is clear is that eye health experts have advice for people using artificial tears, which are sold over the counter and widely used for eye irritation associated with dry eye disease, contact lens use, and refractive surgery, as well among those using other eye drops regularly, such as for glaucoma. NIH, National Eye Institute (NEI) Early anti-VEGF treatment of diabetic retinopathy yields no benefit to visual acuity /articles/early-anti-vegf-treatment-of-diabetic-retinopathy-yields-no-benefit-to-visual-acuity/?sc=rsin /articles/early-anti-vegf-treatment-of-diabetic-retinopathy-yields-no-benefit-to-visual-acuity/?sc=rsin Tue, 07 Feb 2023 11:00:00 EST While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from the DRCR Retina Network. NIH, National Eye Institute (NEI)